Fuso Pharmaceutical Industries

Fuso Pharmaceutical Industries is a prominent entity operating within the Drug Stores & Pharmacies sector, established in 1937. The organization maintains a robust operational footprint with a focus on pharmaceutical manufacturing and retail distribution. Currently, the company supports a workforce of 1,000-5,000 employees, facilitating its complex supply chain and market reach across the Asia-Pacific region. Meet Fuso Pharmaceutical Industries's team to understand the leadership driving these pharmaceutical operations.

Financially, Fuso Pharmaceutical Industries demonstrates significant market stability, reporting annual revenue of $369.8M. The company is publicly traded on the Tokyo Stock Exchange under the ticker TYO: 4538, reflecting its long-standing presence in the Japanese healthcare market. Its core business model integrates pharmaceutical development with retail pharmacy services, ensuring a comprehensive approach to drug distribution and patient care. The firm continues to leverage its historical expertise to maintain competitive positioning within the highly regulated pharmaceutical industry.

Headquartered in Osaka, Japan, at Doshomachi 1-7-10, the company manages its primary operations from this central hub. With a singular primary location, Fuso Pharmaceutical Industries optimizes its logistics and administrative functions to serve its B2C client base effectively. The company remains committed to advancing pharmaceutical standards through its specialized product offerings and strategic market engagement. By focusing on core competencies in drug manufacturing and retail, the firm sustains its operational efficiency and continues to contribute to the broader healthcare infrastructure in Japan and beyond.